Subscribe to Newsletter
Business & Regulation Bioprocessing - Upstream & Downstream
Sanofi’s Push for Pricing Flexibility in the UK

| 6 min read

We speak with Sanofi’s Anju Bhalla about its appeal against NICE’s final draft guidance for Sarclisa.

Manufacture Technology and Equipment

Using AI to Conquer the Undruggable

| 2 min read

AI is set to be a key disruptor in the pharma industry. Here are two perspectives on how it could change drug development.

Business & Regulation Profession

Maintaining Momentum

| 4 min read

Being part of the cell and gene therapy field is an incredible privilege, according to Frank Mathias, CEO, OXB.

Business & Regulation Standards & Regulation

Robert F. Kennedy Jr Nomination Advances

| Stephanie Vine | 2 min read

Senate committee votes in favor of the nomination; full Senate vote will be next.

Register to personalize your newsfeed
Create Account

Latest Articles

Manufacture Advanced Medicine

Digital Twins in CAR-T Manufacturing

| Marc-Olivier Baradez | 4 min read

Here’s why the Cell and Gene Therapy Catapult is excited about the potential of digital twin technology.

Manufacture Vaccines

Understanding the H5N1 Threat

| Stephanie Vine | 4 min read

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Discovery & Development Clinical Trials

AI in Oncology: The Bridge Between the Patient and the Practice

| 2 min read

Using AI to improve oncology care and find the right clinical trials for patients.

Manufacture Bioprocessing - Single Use Systems

ADCs: When Bioprocessing Becomes Toxic

| Alexander Fuchs | 3 min read

Doing more to ease the challenges of antibody drug conjugate manufacturing.

Discovery & Development Clinical Trials

Asking the Right Questions in R&D

| 3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Business & Regulation Standards & Regulation

Panic in US Science

| Stephanie Vine | 3 min read

The Trump administration’s move to pause federal funding while projects are vetted causes concern and lawsuits

Business & Regulation Standards & Regulation

Preparing for the Next Trump Presidency

| 6 min read

What can we expect the US life sciences sector to look like over the course of the next four years as Donald Trump takes up his presidency?

Business & Regulation Trends & Forecasts

mRNA Trend Setters

| 2 min read

Why mRNA will be a key disrupter in the coming years; experts from CureVac and Omega Therapeutics give their views.

Business & Regulation Standards & Regulation

Video Interview: Claus Zieler of Astellas and EFPIA

| Stephanie Vine

Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe.

Discovery & Development Drug Discovery

The Trick With Senolytics

| 4 min read

How understanding and manipulating senescence dynamics could optimize cancer therapies and improve patient outcomes.

All Articles

Upcoming Event

-
Discover Cutting-Edge Pharma Innovations at INTERPHEX – Network, Learn, and Innovate Now!

New York, USA

Join over 9,000 industry professionals at INTERPHEX, the premier global pharmaceutical and biotechnology event. Held...

All Events

Sister Publications

You might be interested in our Sister Publications:



Discovery & Development
Manufacture
Business & Regulation
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register